These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 29576315)

  • 1. Liver induced transgene tolerance with AAV vectors.
    Keeler GD; Markusic DM; Hoffman BE
    Cell Immunol; 2019 Aug; 342():103728. PubMed ID: 29576315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complex and evolving story of T cell activation to AAV vector-encoded transgene products.
    Mays LE; Wilson JM
    Mol Ther; 2011 Jan; 19(1):16-27. PubMed ID: 21119617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodominant liver-specific expression suppresses transgene-directed immune responses in murine pompe disease.
    Zhang P; Sun B; Osada T; Rodriguiz R; Yang XY; Luo X; Kemper AR; Clay TM; Koeberl DD
    Hum Gene Ther; 2012 May; 23(5):460-72. PubMed ID: 22260439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of regulatory T cells in gene transfer.
    Cao O; Furlan-Freguia C; Arruda VR; Herzog RW
    Curr Gene Ther; 2007 Oct; 7(5):381-90. PubMed ID: 17979684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to AAV in clinical trials.
    Mingozzi F; High KA
    Curr Gene Ther; 2007 Oct; 7(5):316-24. PubMed ID: 17979678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BALB/c mice show impaired hepatic tolerogenic response following AAV gene transfer to the liver.
    Breous E; Somanathan S; Wilson JM
    Mol Ther; 2010 Apr; 18(4):766-74. PubMed ID: 20068550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice.
    Zhu J; Huang X; Yang Y
    J Clin Invest; 2009 Aug; 119(8):2388-98. PubMed ID: 19587448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV as an immunogen.
    Vandenberghe LH; Wilson JM
    Curr Gene Ther; 2007 Oct; 7(5):325-33. PubMed ID: 17979679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses to AAV in clinical trials.
    Mingozzi F; High KA
    Curr Gene Ther; 2011 Aug; 11(4):321-30. PubMed ID: 21557723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL12-mediated liver inflammation reduces the formation of AAV transcriptionally active forms but has no effect over preexisting AAV transgene expression.
    Gil-Fariña I; Di Scala M; Vanrell L; Olagüe C; Vales A; High KA; Prieto J; Mingozzi F; Gonzalez-Aseguinolaza G
    PLoS One; 2013; 8(7):e67748. PubMed ID: 23844082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Skeletal Muscle Environment and Its Role in Immunity and Tolerance to AAV Vector-Mediated Gene Transfer.
    Boisgerault F; Mingozzi F
    Curr Gene Ther; 2015; 15(4):381-94. PubMed ID: 26122097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of FoxP3
    Muñoz-Melero M; Biswas M
    Hum Gene Ther; 2024 Jul; 35(13-14):439-450. PubMed ID: 38450566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Balance between CD8
    Kumar SRP; Hoffman BE; Terhorst C; de Jong YP; Herzog RW
    Mol Ther; 2017 Apr; 25(4):880-891. PubMed ID: 28284982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved induction of immune tolerance to factor IX by hepatic AAV-8 gene transfer.
    Cooper M; Nayak S; Hoffman BE; Terhorst C; Cao O; Herzog RW
    Hum Gene Ther; 2009 Jul; 20(7):767-76. PubMed ID: 19309290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of transgene-encoded protein after neonatal injection of adeno-associated virus improves hepatic copy number without immune responses.
    Tai DS; Hu C; Kim EH; Lipshutz GS
    Pediatr Res; 2015 Sep; 78(3):239-246. PubMed ID: 26042522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver.
    Martino AT; Suzuki M; Markusic DM; Zolotukhin I; Ryals RC; Moghimi B; Ertl HC; Muruve DA; Lee B; Herzog RW
    Blood; 2011 Jun; 117(24):6459-68. PubMed ID: 21474674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.
    Zaiss AK; Muruve DA
    Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can genes transduced by adeno-associated virus vectors elicit or evade an immune response?
    Wang CH; Liu DW; Tsao YP; Xiao X; Chen SL
    Arch Virol; 2004 Jan; 149(1):1-15. PubMed ID: 14689272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression.
    Mueller C; Chulay JD; Trapnell BC; Humphries M; Carey B; Sandhaus RA; McElvaney NG; Messina L; Tang Q; Rouhani FN; Campbell-Thompson M; Fu AD; Yachnis A; Knop DR; Ye GJ; Brantly M; Calcedo R; Somanathan S; Richman LP; Vonderheide RH; Hulme MA; Brusko TM; Wilson JM; Flotte TR
    J Clin Invest; 2013 Dec; 123(12):5310-8. PubMed ID: 24231351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate Immune Sensing of Adeno-Associated Virus Vectors.
    Cao D; Byrne BJ; de Jong YP; Terhorst C; Duan D; Herzog RW; Kumar SRP
    Hum Gene Ther; 2024 Jul; 35(13-14):451-463. PubMed ID: 38887999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.